切换至 "中华医学电子期刊资源库"
高级检索
中华脑血管病杂志(电子版)

中华脑血管病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 188 -193. doi: 10.11817/j.issn.1673-9248.2020.04.001

所属专题： 文献；

专家论坛

特发性颅内高压症与颅内静脉窦狭窄诊疗现状及展望
王族1, 宋海庆1,†()   
  1. 1. 100053　北京，首都医科大学宣武医院神经内科
  • 收稿日期:2020-04-23 出版日期:2020-08-01
  • 通信作者: 宋海庆
  • 基金资助:
    国家重点研发计划重大慢性非传染性疾病防控研究重点专项(2016YFC1300600)

Idiopathic intracranial hypertension and intracranial venous sinus stenosis: current status and prospects

Zu Wang1, Haiqing Song1,†()   

  1. 1. Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing 100053, China
  • Received:2020-04-23 Published:2020-08-01
  • Corresponding author: Haiqing Song
  • About author:
    Corresponding author: Song Haiqing, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王族, 宋海庆. 特发性颅内高压症与颅内静脉窦狭窄诊疗现状及展望[J]. 中华脑血管病杂志(电子版), 2020, 14(04): 188-193.

Zu Wang, Haiqing Song. Idiopathic intracranial hypertension and intracranial venous sinus stenosis: current status and prospects[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2020, 14(04): 188-193.

特发性颅内高压症（IIH）是一种以颅内压增高为主要症状，以伴随的相关临床表现及体征为特征的临床综合征。而颅内静脉窦狭窄是一种少见的脑血管病，其确切病因尚不明确。目前学界广为接受的一种观点是，颅内静脉窦静脉狭窄是IIH的病因之一。在多项研究中，90%的IIH患者磁共振成像证实存在横窦狭窄。颅内静脉窦狭窄的临床表现及体征多与颅内高压症相关，如头痛、视乳头水肿、视物模糊、耳鸣等。尽管如此，仍有少部分的脑静脉狭窄患者未患有IIH，此类患者与患有IIH的患者特点存在差异。本文着眼于颅内静脉窦狭窄的诊疗，并比较各种治疗手段之间的差异。

关键词: 脑静脉狭窄, 颅内静脉窦狭窄, 特发性颅内高压症

Idiopathic intracranial hypertension (IIH) is a clinical syndrome characterized by an increase of intracranial pressure and is accompanied by associated clinical symptoms and signs. Intracranial sinus stenosis is a rare cerebrovascular disease, and its exact etiology is unknown. A widely accepted academic view is that intracranial venous sinus vein stenosis is one of the causes of IIH. In multiple studies, 90% of patients with IIH have been confirmed to be with transverse sinus stenosis by magnetic resonance imaging. Its clinical manifestations are mostly related to intracranial hypertension, such as headache, papillary edema, blurred vision, and tinnitus. Nevertheless, a small number of patients with cerebral venous stenosis do not have IIH, and these patients have different characteristics from those with IIH. This article looked at the diagnosis and treatment of intracranial sinus stenosis and compared the differences between various treatments.

Key words: Cerebral vein stenosis, Intracranial sinus stenosis, Idiopathic intracranial hypertension
1
Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature [J]. J Neurointerv Surg, 2013, 5(5): 483-486.
2
Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study [J]. Stroke, 2001, 32(12): 2735-2740.
3
Farb R, Vanek I, Scott J, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis [J]. Neurology, 2003, 60(9): 1418-1424.
4
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension [J]. Neurology, 2002, 59(10): 1492-1495.
5
Durcan PJ, Corbett JJ, Wall M. The Incidence of Pseudotumor Cerebri: Population Studies in Iowa and Louisiana [J]. Arch Neurol, 1988, 45(8): 875-877.
6
De Simone R, Ranieri A, Montella S, et al. The role of dural sinus stenosis in idiopathic intracranial hypertension pathogenesis: the self-limiting venous collapse feedback-loop model [J]. Panminerva medica, 2014, 56(3): 201-209.
7
Levitt MR, Albuquerque FC, Gross BA, et al. Venous sinus stenting in patients without idiopathic intracranial hypertension [J]. J Neurointerv Surg, 2017, 9(5): 512-515.
8
Marmarou A, Shulman K, Rosende RM. A nonlinear analysis of the cerebrospinal fluid system and intracranial pressure dynamics [J]. J Neurosurg, 1978, 48(3): 332.
9
Stevens SA, Previte M, Lakin WD, et al. Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study [J]. Math Med Biol, 2007, 24(1): 85-109.
10
Durst CR, Ornan DA. Prevalence of dural venous sinus stenosis and hypoplasia in a generalized population [J]. J Neurointerv Surg, 2016, 8(11): 1173-1177.
11
Dinkin MJ, Patsalides A. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial [J]. J Neuroophthalmol, 2017, 37(2): 113-121.
12
McCormick MW, Bartels HG, Rodriguez A, et al. Anatomical Variations of the Transverse-Sigmoid Sinus Junction: Implications for Endovascular Treatment of Idiopathic Intracranial Hypertension [J]. Anat Rec (Hoboken), 2016, 299(8): 1037-1042.
13
Matloob SA, Toma AK, Thompson SD, et al. Effect of venous stenting on intracranial pressure in idiopathic intracranial hypertension [J]. Acta Neurochir (Wien), 2017, 159(8): 1429-1437.
14
Dinkin MJ, Patsalides A. Venous Sinus Stenting for Idiopathic Intracranial Hypertension: Where Are We Now? [J]. Neurol Clin, 2017, 35(1): 59-81.
15
Satti SR, Leishangthem L, Spiotta A, et al. Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension [J]. Interv Neuroradiol, 2017, 23(2): 186-193.
16
Smith KA, Peterson JC, Arnold PM, et al. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography [J]. Int J Neurosci, 2017, 127(2): 145-153.
17
Zhou D, Meng R, Zhang X, et al. Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting [J]. Eur J Neurol, 2018, 25(2): 365-e13.
18
Lazzaro MA, Darkhabani Z, Remler BF, et al. Venous sinus pulsatility and the potential role of dural incompetence in idiopathic intracranial hypertension [J]. Neurosurgery, 2012, 71(4): 877-883.
19
Xu K, Yu T, Yuan Y, et al. Current Status of the Application of Intracranial Venous Sinus Stenting [J]. Int J Med Sci, 2015, 12(10): 780-789.
20
Mathis JM, Mattox D, Malloy P, et al. Endovascular treatment of pulsatile tinnitus caused by dural sinus stenosis [J]. Skull Base Surg, 1997, 7(3): 145-150.
21
Li Baomin, Shi Yongbing, Cao Xiangyu. Angioplasty and stenting for intractable pulsatile tinnitus caused by dural venous sinus stenosis: a case series report [J]. Otol Neurotol, 2014, 35(2): 366-370.
22
Montella S, Ranieri A, Marchese M, et al. Primary stabbing headache: a new dural sinus stenosis-associated primary headache? [J]. Neurol Sci, 2013, 34 Suppl 1: S157-S159.
23
Mokin M, Kan P, Abla AA, et al. Intravascular ultrasound in the evaluation and management of cerebral venous disease [J]. World Neurosurg, 2013, 80(5): 655.e7-13.
24
Meng R, D3rd Dornbos, Meng L, et al. Clinical differences between acute CVST and non-thrombotic CVSS [J]. Clin Neurol Neurosurg, 2012, 114(9): 1257-1262.
25
Radvany MG, Solomon D, Nijjar S, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis [J]. J Neuroophthalmol, 2013, 33(2): 117-122.
26
Shazly TA, Jadhav AP, Aghaebrahim A, et al. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis [J]. J Neurointerv Surg, 2018, 10(3): 310-314.
27
Esfahani DR, Stevenson M, Moss HE, et al. Quantitative Magnetic Resonance Venography is Correlated With Intravenous Pressures Before and After Venous Sinus Stenting: Implications for Treatment and Monitoring [J]. Neurosurgery, 2015, 77(2): 254-260.
28
West JL, Greenway GP, Garner RM. Correlation between angiographic stenosis and physiologic venous sinus outflow obstruction in idiopathic intracranial hypertension [J]. J Neurointerv Surg, 2019, 11(1): 90-94.
29
Biousse V, Bousser MG. Benign intracranial hypertension [J]. Rev Neurol (Paris), 2001, 157(1): 21-34.
30
Spitze A, Malik A, Lee AG. Surgical and endovascular interventions in idiopathic intracranial hypertension [J]. Curr Opin Neurol, 2014, 27(1): 69-74.
31
Ducruet A, Crowley R, McDougall C, et al. Long-term patency of venous sinus stents for idiopathic intracranial hypertension [J]. J Neurointerv Surg, 2014, 6(3): 238-242.
32
Satti SR, Leishangthem L, Chaudry MI. Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension [J]. AJNR Am J Neuroradiol, 2015, 36(10): 1899-1904.
33
Aguilar-Pérez M, Martinez-Moreno R, Kurre W, et al. Endovascular treatment of idiopathic intracranial hypertension: retrospective analysis of immediate and long-term results in 51 patients [J]. Neuroradiology, 2017, 59(3): 277-287.
34
West JL, Garner RM. Venous waveform morphological changes associated with treatment of symptomatic venous sinus stenosis [J]. J Neurointerv Surg, 2018, 10(11): 1108-1113.
35
Liu K, Starke R, Durst C, et al. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study [J]. J Neurosurg, 2017, 127(5): 1126-1133.
36
Goodwin CR, Elder BD, Ward A, et al. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients [J]. Clin Neurol Neurosurg, 2014, 127: 75-78.
37
Qureshi A, Khan A, Capistrant R, et al. Concurrent Angioplasty Balloon Placement for Stent Delivery through Jugular Venous Bulb for Treating Cerebral Venous Sinus Stenosis. Technical Report [J]. J Vasc Interv Neurol, 2016, 9(2): 55-61.
38
Paquet C, Poupardin M, Boissonnot M, et al. Efficacy of unilateral stenting in idiopathic intracranial hypertension with bilateral venous sinus stenosis: a case report [J]. Eur Neurol, 2008, 60(1): 47-48.
39
Raper D, Buell TJ, Ding D, et al. Pattern of pressure gradient alterations after venous sinus stenting for idiopathic intracranial hypertension predicts stent-adjacent stenosis: a proposed classification system [J]. J Neurointerv Surg, 2018, 10(4): 391-395.
No related articles found!
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号